Opportunistic Salpingectomy Reduces Ovarian Cancer Risk by 78%, Experts Call It a 'No-Brainer'
核心洞察
Research shows women who had fallopian tubes removed during another surgery had a 78% lower risk of the most common type of ovarian cancer (搜索).
Most ovarian cancers originate in the fallopian tubes, not the ovaries, a finding first identified in 2001 and strengthened over 25 years of research.
Major medical societies including ACOG and SGO now recommend fallopian tube removal to reduce ovarian cancer (搜索) risk in women done with childbearing.
A growing body of evidence supports the removal of fallopian tubes during other abdominal or pelvic surgeries as a powerful strategy to reduce ovarian cancer (搜索) risk—and experts are now calling the procedure a "no-brainer" for women who have completed childbearing.
Research published earlier this year found that women who had their fallopian tubes removed during another surgery had a 78% lower risk of the most common type of ovarian cancer (搜索) compared to those who kept their tubes. The procedure, known as opportunistic salpingectomy, has gained momentum as scientific understanding of ovarian cancer's origins has shifted dramatically over the past two decades.
"In my opinion now, if you're done childbearing, that's very clear in your mind, and a surgeon is going to be in your abdomen for whatever purpose, whether it be a gynecologic indication or a non-gynecologic, I think with the data that we have now, it's really a no-brainer to have your fallopian tubes out at the same time, as long as it can be safely performed," says Larissa A. Meyer, M.D., M.P.H., FACOG, FACS, a professor of gynecologic oncology at MD Anderson Cancer Center.
The Fallopian Tube Connection
The paradigm shift began in 2001, when scientists in the Netherlands discovered precancerous changes inside the fallopian tubes of women with genetic risk factors for ovarian cancer (搜索). This finding challenged the long-held assumption that ovarian cancer originated in the ovaries themselves.
"The cells lining the fallopian tubes are constantly growing, shedding, and changing," explains Vinita Popat, M.D., a gynecologic oncology fellow at City of Hope (搜索). "There are little mutations that can happen in the fallopian tube cells that eventually, through a cascade, one mutation occurs, and then another mutation occurs, and then another mutation occurs, and over time, these cells evolve to develop the cancer."
Over the past 25 years, research has consistently strengthened the understanding that many, though not all, ovarian cancers start in the fallopian tubes before spreading into the abdomen. This biological insight has opened the door to a prevention strategy that avoids the significant downsides of ovary removal.
Preserving Hormonal Function
Traditional risk-reducing surgery for women with genetic mutations such as BRCA1 (搜索) or BRCA2 (搜索) has involved removing both the ovaries and fallopian tubes. However, ovary removal triggers immediate surgical menopause, bringing hot flashes, mood swings, bone loss, sexual dysfunction, and long-term risks including heart disease and cognitive deficits.
By removing only the fallopian tubes, women can achieve what researchers hope is meaningful ovarian cancer (搜索) prevention without the cost of early menopause. "I think going through menopause early is a big cost," says Wilke, a clinician at MD Anderson. "This allows women to get what we hope is ovarian cancer prevention, but not at the expense of going into menopause so early."
Dr. Meyer reinforces this point: "It doesn't affect things like your ovarian function, so you wouldn't have to worry about premature menopause or anything like that."
Growing Adoption and Remaining Barriers
The procedure has seen sharp increases in adoption. From 2011 to 2022, the rate of women who chose to have their tubes removed rather than tied jumped from 0.1% to 14.6% among postpartum women and from 1.4% to 65.9% in women outside the postpartum period.
Major medical organizations—including the American College of Obstetricians and Gynecologists, the Society of Gynecologic Oncology, the European Society of Gynaecological Oncology, and the International Federation of Gynecology and Obstetrics—now recommend fallopian tube removal to reduce ovarian cancer (搜索) risk.
However, barriers remain. Until 2025, medical centers lacked a diagnostic code to bill insurance for this surgery when performed for cancer prevention in people without known genetic risk factors. "We now have a way for it to be recognized as a procedure and reimbursed for normal-risk women," says Dr. Meyer.
Access also varies geographically. Not all states recognize fallopian tube removal as a form of sterilization covered by Medicaid, limiting accessibility for some women. "This is where you see sort of the intersection of what we know medically and the infrastructure that we have to work within in our systems to actually implement this more broadly," Dr. Meyer notes.
Additionally, historical mistrust in the medical community—particularly around sterilization without consent—creates cultural barriers that must be navigated carefully. "Historically, there's some distrust in certain communities about people who were sterilized without their consent or without their knowledge," says Dr. Meyer.
Clinical Context
Ovarian cancer (搜索) remains the fifth-deadliest cancer for women. There is no standard screening test to catch it early, and it is normally diagnosed once it has reached stage three and spread throughout the entire abdomen. "People have signs of bloating and abdominal pain, and they may have a mass on their ovaries, but it may just be these general, nonspecific symptoms," says Dr. Popat.
For women with known genetic risk factors such as BRCA mutations, risk-reducing surgery that includes ovary removal remains the standard recommendation. But for average-risk women undergoing other surgeries—from hysterectomies and Cesarean sections to gallbladder or appendix removal—adding fallopian tube removal adds minimal operative time and risk. "When you do it at the time of a hysterectomy, or a Cesarean section, or instead of getting your tubes tied, it doesn't add much time, maybe 10 or 15 minutes max," says Dr. Meyer. "It can be very fast and safe."
MD Anderson has several clinical trials underway to explore the benefits of salpingectomies without oophorectomies in women at both high risk and average risk, and Dr. Meyer and other researchers are studying opportunities to incorporate more fallopian tube removals into nongynecological procedures.